Paxil CR

Paxil CR (Paroxetine Hydrochloride Controlled-Release): Evidence-Based Profile for the Management of Major Depressive Disorder, Panic Disorder, and Social Anxiety Disorder Indications and Clinical Use: Paxil CR is indicated for the acute and maintenance treatment of Major Depressive Disorder (MDD), Panic Disorder with or without agoraphobia, Social Anxiety Disorder (Social Phobia), Premenstrual Dysphoric Disorder (PMDD), and Post-Traumatic Stress Disorder (PTSD). This controlled-release formulation is designed to mitigate the early-onset activation and nausea commonly associated with immediate-release paroxetine.